Status:
COMPLETED
Role of Suppression of Endometriosis With Progestins Before IVF-ET
Lead Sponsor:
National Research Centre, Egypt
Conditions:
IVF
Endometriosis
Eligibility:
FEMALE
30-40 years
Phase:
NA
Brief Summary
This study aimed to assess the role of Dienogest pretreatment for endometriosis suppression as compared to Gonadotropin-releasing hormone agonist (GnRHa) in patients with endometriosis pursuing IVF tr...
Eligibility Criteria
Inclusion
- confirmed diagnosis of endometriosis
- body mass index \< 35 Kg/m2
Exclusion
- if they have been already on long-term down-regulation of the pituitary gland with GnRHa for control of endometriosis
- liver or kidney disease
- evidence of diminished ovarian reserve (e.g. high FSH level \>12 IU/L or low AMH level \<1 ng/ml).
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT04500743
Start Date
August 1 2018
End Date
April 30 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia Infertility research unit
Minya, Egypt